美國拒絕多間企業就中國製汽車部件關稅豁免申請
《路透》報道,美國貿易代表辦公室拒絕多間企業就中國製造汽車部件免徵25%關稅的申請。
其中美國電動車生產商特斯拉(Tesla)的中國製車用電腦與中央屏幕,被指具戰略重要性、與「中國製造2025」或其他中國工業政策有關。通用汽車的逾50項豁免申請亦被拒,涉及混能車及電動車使用高壓電池控制器的電子控制器、高頻率天線、車輛啟動開關按鈕、電池連接線、電動單車部件及煞車部件。
優步要求免除中國製電動單車關稅的申請亦被拒。該等單車供用戶透過應用程序租用。日產汽車及快意佳士拿提出的電線束及轉向泵亦遭拒。
當局早前拒絕向通用汽車及沃爾沃汽車在中國生產的運動型乘用車(SUV)豁免關稅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.